ArticleCureus2026
Large Cutaneous Mixed Tumor of Apocrine Type Formerly Known As Chondroid Syringoma: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Large subcutaneous masses are relatively uncommon and usually benign. Lipomatous tumors predominate and are typically nonmalignant; however, atypical lipomatous tumors and liposarcomas can occur. Although malignancy is uncommon overall, soft tissue sarcomas may present as large or deep subcutaneous masses. A woman in her 50s presented to the primary care clinic with a large, firm, and mobile mass on the posterior aspect of the left shoulder that had been present for seven years. After excisional biopsy, pathological evaluation confirmed the diagnosis of cutaneous mixed tumor, apocrine type (chondroid syringoma). Cutaneous mixed tumor is a rare and typically benign neoplasm that can arise from either eccrine or apocrine glands and typically presents as a slow-growing, painless nodule. Definitive management and treatment involve surgical excision with a goal of removal of the entire tumor to avoid both recurrence and rare instances of malignant transformation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.